2,4-Dichloro-6-methylpyrimidine - CAS 5424-21-5
Catalog: |
BB028575 |
Product Name: |
2,4-Dichloro-6-methylpyrimidine |
CAS: |
5424-21-5 |
Synonyms: |
2,4-dichloro-6-methylpyrimidine |
IUPAC Name: | 2,4-dichloro-6-methylpyrimidine |
Description: | 2,4-Dichloro-6-methylpyrimidine (CAS# 5424-21-5) is a compound useful in organic synthesis. |
Molecular Weight: | 163.00 |
Molecular Formula: | C5H4Cl2N2 |
Canonical SMILES: | CC1=CC(=NC(=N1)Cl)Cl |
InChI: | InChI=1S/C5H4Cl2N2/c1-3-2-4(6)9-5(7)8-3/h2H,1H3 |
InChI Key: | BTLKROSJMNFSQZ-UHFFFAOYSA-N |
Boiling Point: | 219 °C |
Melting Point: | 43-47 °C |
Purity: | 95 % |
Density: | 1.404 g/cm3 |
Appearance: | Light yellow prismatic crystal |
Storage: | Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances. Corrosives area. |
MDL: | MFCD00006064 |
LogP: | 2.09180 |
GHS Hazard Statement: | H314 (97.87%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113072541-A | Preparation method of targeted drug BLU-667 | 20210402 |
WO-2021195279-A2 | Small molecule inhibitors of oncogenic chd1l with preclinical activity against colorectal cancer | 20200324 |
CN-110790711-A | Preparation method of 2-chloro-4-amino-6-methylpyrimidine compound | 20191129 |
WO-2021097352-A1 | Isoxazole derivatives targeting tacc3 as anticancer agents | 20191114 |
CN-112574212-A | Pyrimido five-membered nitrogen heterocyclic derivative, preparation method and medical application thereof | 20190930 |
PMID | Publication Date | Title | Journal |
21462944 | 20110520 | 4-Arylvinyl-2,6-di(pyridin-2-yl)pyrimidines: synthesis and optical properties | The Journal of organic chemistry |
19966921 | 20091118 | Design and Synthesis of Imidazopyrimidine Derivatives as Potent iNOS Dimerization Inhibitors | The open medicinal chemistry journal |
12659561 | 20030403 | Fluorous synthesis of disubstituted pyrimidines | Organic letters |
Complexity: | 99 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 161.9751535 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 2 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 161.9751535 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 25.8 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.5 |
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB035854
(1-Bromocyclopropyl)benzene
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB078021
(1-(3-Bromo-5-fluorophenyl)cyclopropyl)methanamine
Detail
-
Catalog: BB079894
((3-Bromo-4-fluorophenyl)ethynyl)trimethylsilane
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
-
Catalog: BB054190
(-)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS